Abstract
HFE-hemochromatosis is a common autosomal recessive disease caused by HFE gene mutations and characterized as iron overload and failure of different organs. The aim of this study was to determine the prevalence of C282Y (c.845 G > A), H63D (c.187 C > G), and S65C (c.193A > T) alleles of HFE gene in the Lithuanian population. One thousand and eleven healthy blood donors of Lithuanian nationality were examined in four different ethnic Lithuanian regions to determine HFE gene alleles and genotype frequencies. The samples of DNA were analyzed for the presence of restriction fragment length polymorphism and validated by DNA sequencing. Among 1,011 blood donors tested, the frequency of C282Y, H63D, and S65C alleles were 2.6%, 15.9%, and 1.9%, respectively. One third of the tested subjects (n = 336) had at least one of the C282Y or H63D HFE gene mutations. The screening of Lithuanian blood donors has detected 13 (1.3%) subjects with a genotype C282Y/C282Y or C282Y/H63D responsible for the development of HFE-hemochromatosis. The prevalence of C282Y mutation was significantly higher among the inhabitants of Zemaitija (Somogitia) at the Baltic Sea area (5.9%) in comparison to the regions of continental part of Lithuania (2.4% in Dzukija, 2.3% in Aukstaitija, and 2% in Suvalkija, p < 0.05). These data support the hypothesis that the p.C282Y mutation originated from Scandinavia and spread with the Vikings along the Baltic Sea coast. The first epidemiological investigation of HFE gene mutations in ethnic Lithuanians showed that the frequencies of H63D, C282Y, and S65C of HFE gene alleles are similar to the other North-Eastern Europeans, especially in the Baltic region (Estonia, Latvia), Poland, and part of Russia (Moscow region).
Similar content being viewed by others
References
Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408. doi:10.1038/ng0896-399, Medline
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Milman N, Pedersen P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 64:36–47. doi:10.1034/j.1399-0004.2003.00083.x, Medline
Byrnes V, Ryan E, Barrett S, Kenny P, Mayne P, Crowe J (2001) Genetic hemochromatosis, a Celtic disease: is it now time for population screening? Genet Test 5:127–130. doi:10.1089/109065701753145583, Medline
Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M (2001) HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 114:474–484. doi:10.1046/j.1365-2141.2001.02949.x, Medline
Distante S, Berg JP, Lande K, Haug E, Bell H (2000) HFE gene mutation (C282Y) and phenotypic expression among a hospitalized population in a high prevalence area of haemochromatosis. Gut 47:575–579. doi:10.1136/gut.47.4.575, Medline
Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278
Beckman LE, Sjoberg K, Eriksson S, Beckman L (2001) Haemochromatosis gene mutations in Finns, Swedes and Swedish Saamis. Hum Hered 52:110–112. doi:10.1159/000053362, Medline
Holmstrom P, Marmur J, Eggertsen G, Gafvels M, Stal P (2002) Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 51:723–730. doi:10.1136/gut.51.5.723, Medline
Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, de Sousa M et al (1998) HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 243:203–208. doi:10.1046/j.1365-2796.1998.00270, Medline
Pedersen P, Melsen GV, Milman N (2008) Frequencies of the haemochromatosis gene (HFE) variants C282Y, H63D and S65C in 6,020 ethnic Danish men. Ann Hematol 87:735–740. doi:10.1007/s00277-008-0506-8, Medline
Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K (2001) Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 80:737–744. doi:10.1007/s002770100371, Medline
Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, larsen LE, Appleyard M, Frandsen M et al (2001) Prevalence of hereditary haemochromatosis in late-onset type I diabetes mellitus: a retrospective study. Lancet 358:1405–1409. doi:10.1016/S0140-6736(01)06526-6, Medline
Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Norgaard-Pedersen B, Robson KJ (1999) A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 13:154–159. doi:10.1002/(SICI)1098-1004, (1999) 13:2<154::AID-HUMU8>3.0 CO;2-E
Moczulski DK, Grzeszczak W, Gawlik B (2001) Frequency of the hemochromatosis C282Y and H63D mutations in a Polish population of Slavic origin. Med Sci Monit 7(3):441–443
Parlist P, Mikelsaar AV, Tasa G, Beckman L (2001) The frequency of C282Y and H63D mutations in Hemochromatosis gene in native Estonians. Eur J Epidemiol 17:213–216. doi:10.1023/A:1017951314164, Medline
Potekhina ES, Lavrov AV, Samokhodskaya LM et al (2005) Unique genetic profile of hereditary hemochromatosis in Russians: high frequency of C282Y mutation in population, but not in patients. Blood Cells Mol Dis 35:182–188. doi:10.1016/j.bcmd.2005.06.012, Medline
Cimburova M, Putova I, Provaznikova H et al (2005) S65C and other mutations in the haemochromatosis gene in the Czech population. Folia Biol (Praha) 51:172–176
Cukjati M, Vaupotic T, Rupreht R, Curin-Serbec V (2007) Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay. BMC Med Genet 8:69. doi:10.1186/1471-2350-8-69, Medline
Ristic S, Makuc J, Starcevic N, Logar N, Brajenovic-Milic B, Stepec S, Plesa I, Kapovic M, Milic S, Stimac D, Crnic-Martinovic M, Peterlin B (2003) Hemochromatosis gene mutations in the Croatian and Slovenian populations. Clin Genet 64(5):444–446. doi:10.1034/j.1399-0004.2003.00169.x, Medline
Papazoglu D, Exiara T, Speletas M et al (2003) Prevalence of hemochromatosis gene (HFE) mutations in Greece. Acta Haematol 109:137–140. doi:10.1159/000069289, Medline
Papanikolaou G, Politou M, Terpos E et al (2006) Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity. Blood Cells Mol Dis 26:163–168. doi:10.1006/bcmd.2000.0292, Medline
Vojcu PM, Cojocariu C, Petrescu-Danila E, Covic M, Stanciu C, Rusu M (2009) Prevalence of HFE (hemochromatosis) gene mutations C282Y and H63D in a Romanian population. Blood Cells Mol Dis 42. doi:10.1016/j.bcmd.2008.08.004, Medline
Ivanova A, von Ahsen N, Adjonova D et al (1999) C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in Bulgaria. Hepatology 30:1531–1532. doi:10.1002/hep.510300626, Medline
Ajioka RS, Jorde LB, Gruen JR et al (1997) Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet 60:1439–1447
Distante S, Robson KJH, Graham-Campbell J, Arnaiz-Villena A, Brissot P, Worwood M (2004) The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum Genet 115:269–279. doi:10.1007/s00439-004-1152-4, Medline
de Juan D, Reta A, Castiella A, Pozueta J, Prada A, Cuadrado E (2001) HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls. Eur J Hum Genet 9(12):961–964
Sanchez M, Villa M, Ingelmo M et al (2003) Population screening for hemochromatosis: a study in 5370 Spanish blood donors. J Hepatology Medline:745–750. doi:10.1016/S0168-8278(03)00123-5, Medline
Cardoso CS, Oliveira P, Graca P (2001) Comparative study of the two more frequent HFE mutations (C282Y and H63D): significant different allelic frequencies between the North and South of Portugal. Eur J Hum Genet 9:843–848
Raddatz D, Legler T, Lynen R, Addicks N, Ramadori G (2003) HFE genotype and parameters of iron metabolism in German first time blood donors—evidence for an increased transferrin saturation in C282Y heterozygotes. J Gastroenterol 41:1069–1076. doi:10.1055/s-2003-44299, Medline
Kazemi-Shirazi L, Datz C, Maier-Dobersberger T et al (1999) The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 116:127–134
Syrjakosi K, Fredriksson H, Ikonen T, Kuukasjarvi T, Autio V, Matikainen MP et al (2006) Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients. In J Cancer 118:518–520. doi:10.1002/ijc.21331, Medline
Mura C, Raguenes O, Ferec C (1999) HFE mutation analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 93(8):2502–2505
Acknowledgments
The authors wish to thank all study participants for their cooperation. The study was supported by the Lithuanian State Science and Studies Foundation (No. T-25/09).
Competing interests
The author(s) declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kucinskas, L., Juzenas, S., Sventoraityte, J. et al. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population. Ann Hematol 91, 491–495 (2012). https://doi.org/10.1007/s00277-011-1338-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-011-1338-5